Generics 35

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Flavoxate manufacturers

35 products found

Filters

35 products found

flavoxate

Tablets for oral solution 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

flavoxate

Tablets tbt

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
Manufacturer #1403

Manufacturer usually replies in 8 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

flavoxate

Tablets 100 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #18854

Manufacturer usually replies in 6 days

flavoxate

Tablets, film coated 60 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Manufacturer #31063

Manufacturer usually replies in nan days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

Manufacturer usually replies in 12 days

flavoxate + ofloxacin

Tablets for oral solution 200 mg + 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19861

Manufacturer usually replies in 3 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19097

Manufacturer usually replies in 2 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20504
The company was formed in the 1970s. The company has been holding more than 200 licenses including sugar coating tablets, film coating tablets, enteric coating tablets, granule, powder, capsule, solution, cream, ointment, and suppositories.

Manufacturer usually replies in 10 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20395

Manufacturer usually replies in 9 days

flavoxate

Tablets for oral solution 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19735

Manufacturer usually replies in 8 days

flavoxate

Tablets 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19412

Manufacturer usually replies in 5 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19203

Manufacturer usually replies in 6 days

flavoxate + ofloxacin

Tablets 200 mg+200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19351

Manufacturer usually replies in 12 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19351

Manufacturer usually replies in 12 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Taiwan
GMP approvals
PICS
Manufacturer #20598
The company has a PIC/S GMP-certified pharmaceutical factory that has been approved by the TFDA. In recent years, with the rapid development of science and technology, the mutual penetration and promotion of various disciplines have greatly promoted the development of pharmaceuticals. New methods, new technologies, new equipment, new ingredients and new ingredients in modern drug manufacturing continue to emerge. The basic research has been deepened, applied research has been more perfect, and the development of pharmaceutical dosage forms has entered the era of new drug release systems from traditional dosage forms such as tablets, capsules, and injections. New products of various controlled and sustained-release dosage forms are on the market, and the research on targeted drug delivery preparations and pulse-controlled automatic drug delivery systems is developing rapidly.

Manufacturer usually replies in 18 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20499

Manufacturer usually replies in 75 days

flavoxate

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19242

Manufacturer usually replies in 21 days

flavoxate + ofloxacin

Tablets 200 mg+200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19242

Manufacturer usually replies in 21 days

flavoxate + ofloxacin

Tablets 200 mg+200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19242

Manufacturer usually replies in 21 days

Want to view all 35 products? Create your free account today!

Flavoxate:

Flavoxate is an anticholinergic with antimuscarinic effects, it is used as a medication for its muscle relaxant properties. Where it is used to treat urinary bladder spasms and other similar ailments. It is produced by manufacturers under the trade names of Urispas (Paladin, India), Genurin (Recordati, Italy), Uritac (El Saad company, Syria), Bladderon (Nippon Shinyaku, Japan), Bladuril (Chile), and Utispas (Apex Pharma, Nepal). Flavoxate was originally approved for use in the United States in 1970 and since has become popular in the global medical marketplace. Where, due to its emergence into the generic drugs space, it has seen frequent production and commercialization by flavoxate manufacturers and flavoxate suppliers. It is now often found on the pharmaceutical products for sale list of global distributors, where it is available for wholesale order at a variety of cost and price points.

Method of action of flavoxate:

Flavoxate belongs to a group of drugs which function as spasmolytic flavone derivatives and it specifically functions by relaxing the smooth muscles in the urinary tract. Although the exact mechanism of action remains elusive, it is known that flavoxate functions as a direct antagonist at muscarinic acetylcholine receptors in cholinergic innervated organs. This anticholinergic and parasympatholytic effect reduces the tonus of smooth muscle in the bladder, causing a reduction in the need to urinate and an increase in retention and subsequent volume per urination.

Form and dosage of flavoxate:

The final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, flavoxate typically comes in forms including tablets, film-coated tablets, and capsules. The recommended dose for adult patients for all clinical indications is 200 mg 3 times a day, taken by mouth. Special caution and subsequent dose adjustment should be taken with the elderly and young. Side effects are predominantly non-serious and include constipation, dizziness, and drowsiness. For a complete list of possible complications and additional information please refer to the manufacturers’ literature or an accredited healthcare provider.

Flavoxate on Pipelinepharma:

Currently, at the time of writing, we have found 2 verified flavoxate manufacturers and flavoxate suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in countries including Egypt and Lebanon. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of flavoxate and how to buy:

A cursory search online reveals an approximate wholesale cost for flavoxate to be £11.67 for 200 mg x 90 tablets. These values are indicated for the NHS in the UK. As such they are only intended to serve as a generalization of the current market conditions. Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence. This makes it easy to find new qualified sellers for your pharmaceutical business. Simply use our online search tool, filter by your wanted criteria, and finally select the desired listing.